Loading...
Real-World Lab Data in Natalizumab Treated Multiple Sclerosis Patients Up to 6 Years Long-Term Follow Up
Natalizumab inhibits the transmigration of immune cells across the blood-brain barrier thus inhibiting inflammation in the central nervous system. Generally, this blockade at the blood-brain barrier has significant influence on the circulating lymphocytes. Up to date, only short-term data on periphe...
Na minha lista:
| Udgivet i: | Front Neurol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6292961/ https://ncbi.nlm.nih.gov/pubmed/30581413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2018.01071 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|